Overview MK0524 Seasonal Allergic Rhinitis Study (0524-005)(COMPLETED) Status: Completed Trial end date: 2003-10-01 Target enrollment: Participant gender: Summary To assess the efficacy of MK0524 on seasonal allergies. Phase: Phase 2 Details Lead Sponsor: Merck Sharp & Dohme Corp.